Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia

drugsJuly 25, 2019

Tag: hypoglycemia , glucagon , therapy , FDA

PharmaSources Customer Service